Correlation Between Grupo Aval and MAIA Biotechnology
Can any of the company-specific risk be diversified away by investing in both Grupo Aval and MAIA Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Grupo Aval and MAIA Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Grupo Aval and MAIA Biotechnology, you can compare the effects of market volatilities on Grupo Aval and MAIA Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Grupo Aval with a short position of MAIA Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Grupo Aval and MAIA Biotechnology.
Diversification Opportunities for Grupo Aval and MAIA Biotechnology
-0.63 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Grupo and MAIA is -0.63. Overlapping area represents the amount of risk that can be diversified away by holding Grupo Aval and MAIA Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MAIA Biotechnology and Grupo Aval is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Grupo Aval are associated (or correlated) with MAIA Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MAIA Biotechnology has no effect on the direction of Grupo Aval i.e., Grupo Aval and MAIA Biotechnology go up and down completely randomly.
Pair Corralation between Grupo Aval and MAIA Biotechnology
Given the investment horizon of 90 days Grupo Aval is expected to generate 0.25 times more return on investment than MAIA Biotechnology. However, Grupo Aval is 3.99 times less risky than MAIA Biotechnology. It trades about 0.44 of its potential returns per unit of risk. MAIA Biotechnology is currently generating about 0.01 per unit of risk. If you would invest 207.00 in Grupo Aval on October 25, 2024 and sell it today you would earn a total of 26.50 from holding Grupo Aval or generate 12.8% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Grupo Aval vs. MAIA Biotechnology
Performance |
| Timeline |
| Grupo Aval |
| MAIA Biotechnology |
Grupo Aval and MAIA Biotechnology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Grupo Aval and MAIA Biotechnology
The main advantage of trading using opposite Grupo Aval and MAIA Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Grupo Aval position performs unexpectedly, MAIA Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MAIA Biotechnology will offset losses from the drop in MAIA Biotechnology's long position.| Grupo Aval vs. Banco De Chile | Grupo Aval vs. Banco Santander Chile | Grupo Aval vs. Credicorp | Grupo Aval vs. Foreign Trade Bank |
| MAIA Biotechnology vs. Lineage Cell Therapeutics | MAIA Biotechnology vs. Armata Pharmaceuticals | MAIA Biotechnology vs. Portage Biotech | MAIA Biotechnology vs. Larimar Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Other Complementary Tools
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Transaction History View history of all your transactions and understand their impact on performance |